NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/28/2025
Back to search
Official data from USPTO
CYBREXA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CYBREXA THERAPEUTICS
ST13
US500000087390727Class
42
Filing
87390727
Registration
6080446
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
53
Latest update
11/29/2025
Trademark type
Word
Nice classes
42
Filing date
03/29/2017
Registration date
06/16/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/28/2025
Last transaction
11/29/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/01/2018
First use in commerce
01/01/2018
Drawing code
4
Owner type
03
Owner location
New Haven, CT
Examiner
JOHNSON,CLINTON J
Current location
Historical data usage
Holders and representatives
Holders
Cybrexa, Inc.
Representatives
Patricia A. Olosky SHIPMAN & GOODWIN LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical drug development servicesdevelopment of small molecule drugs for use in humans
Publications
History of USPTO decisions and trademark events.
53 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/28/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/28/2025
E815
TEAS SECTION 8 & 15 RECEIVED
08/13/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/16/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/16/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/12/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/11/2020
ALIE
ASSIGNED TO LIE
05/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/07/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/21/2020
GNRT
NON-FINAL ACTION E-MAILED
04/21/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/21/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/19/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/18/2020
EX5G
SOU EXTENSION 5 GRANTED
03/18/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/18/2020
IUAF
USE AMENDMENT FILED
03/10/2020
EXT5
SOU EXTENSION 5 FILED
03/10/2020
EEXT
SOU TEAS EXTENSION RECEIVED
03/10/2020
EISU
TEAS STATEMENT OF USE RECEIVED
03/10/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/05/2019
EX4G
SOU EXTENSION 4 GRANTED
09/03/2019
EXT4
SOU EXTENSION 4 FILED
09/03/2019
EEXT
SOU TEAS EXTENSION RECEIVED
09/03/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/21/2019
EX3G
SOU EXTENSION 3 GRANTED
02/19/2019
EXT3
SOU EXTENSION 3 FILED
02/19/2019
EEXT
SOU TEAS EXTENSION RECEIVED
02/19/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/13/2018
EX2G
SOU EXTENSION 2 GRANTED
09/11/2018
EXT2
SOU EXTENSION 2 FILED
09/11/2018
EEXT
SOU TEAS EXTENSION RECEIVED
09/11/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/15/2018
EX1G
SOU EXTENSION 1 GRANTED
03/13/2018
EXT1
SOU EXTENSION 1 FILED
03/13/2018
EEXT
SOU TEAS EXTENSION RECEIVED
03/13/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/19/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/25/2017
PUBO
PUBLISHED FOR OPPOSITION
07/25/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/05/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/16/2017
ALIE
ASSIGNED TO LIE
06/07/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/28/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
04/28/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/28/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
04/28/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/28/2017
DOCK
ASSIGNED TO EXAMINER
04/21/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/04/2017
NWAP
NEW APPLICATION ENTERED
04/01/2017
Continuous trademark protection
Get notified about every new filing that threatens CYBREXA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.